The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 18 Nov 2016
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Nov 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 25 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.